Metabolic programs define dysfunctional immune responses in severe COVID-19 patientsElizabeth A. Thompson, Jonathan D. Powell, Katherine Cascino et al.|Cell Reports|2021Cited by 135
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer targetZachary T. Freeman, Charles G. Drake, Anuj Gupta et al.|Journal of Clinical Investigation|2020Cited by 133
Distinct myeloid-derived suppressor cell populations in human glioblastomaChristina Jackson, Drew M. Pardoll, Christopher Cherry et al.|Science|2025Cited by 86
Pervasive promoter hypermethylation of silenced TERT alleles in human cancersDavid Esopi, Srinivasan Yegnasubramanian|Cellular Oncology|2020Cited by 25
A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugsHugh Giovinazzo, Srinivasan Yegnasubramanian|Oncotarget|2019Cited by 18